EKSO Stock Overview
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Ekso Bionics Holdings, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$1.21 |
| 52 Week High | US$3.13 |
| 52 Week Low | US$0.62 |
| Beta | 1.64 |
| 1 Month Change | -11.03% |
| 3 Month Change | -42.38% |
| 1 Year Change | -29.24% |
| 3 Year Change | -78.04% |
| 5 Year Change | -96.51% |
| Change since IPO | -99.51% |
Recent News & Updates
Recent updates
Market Still Lacking Some Conviction On Ekso Bionics Holdings, Inc. (NASDAQ:EKSO)
Dec 20
Sentiment Still Eluding Ekso Bionics Holdings, Inc. (NASDAQ:EKSO)
Jun 19Ekso Bionics: Fragile Opportunity
Aug 24Is Ekso Bionics Holdings (NASDAQ:EKSO) A Risky Investment?
Jun 14Health Check: How Prudently Does Ekso Bionics Holdings (NASDAQ:EKSO) Use Debt?
Feb 05Ekso Bionics: Expecting More Of The Same
Jan 25Is Ekso Bionics Holdings (NASDAQ:EKSO) Weighed On By Its Debt Load?
Sep 22Ekso Bionics: Have Robot, Might Travel
Jul 09Shareholders May Not Be So Generous With Ekso Bionics Holdings, Inc.'s (NASDAQ:EKSO) CEO Compensation And Here's Why
Jun 04Is Ekso Bionics Holdings (NASDAQ:EKSO) Weighed On By Its Debt Load?
May 26What Is The Ownership Structure Like For Ekso Bionics Holdings, Inc. (NASDAQ:EKSO)?
Feb 10
Ekso Bionics sees lower 2020 sales vs. 2019
Jan 13Health Check: How Prudently Does Ekso Bionics Holdings (NASDAQ:EKSO) Use Debt?
Dec 23Ekso Bionics Holdings EPS beats by $0.38, beats on revenue
Oct 29Shareholder Returns
| EKSO | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -6.2% | -4.4% | -3.7% |
| 1Y | -29.2% | -2.8% | 20.2% |
Return vs Industry: EKSO underperformed the US Medical Equipment industry which returned -2.2% over the past year.
Return vs Market: EKSO underperformed the US Market which returned 20.5% over the past year.
Price Volatility
| EKSO volatility | |
|---|---|
| EKSO Average Weekly Movement | 14.4% |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: EKSO's share price has been volatile over the past 3 months.
Volatility Over Time: EKSO's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 71 | Scott Davis | www.eksobionics.com |
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets.
Ekso Bionics Holdings, Inc. Fundamentals Summary
| EKSO fundamental statistics | |
|---|---|
| Market cap | US$21.66m |
| Earnings (TTM) | -US$15.20m |
| Revenue (TTM) | US$18.28m |
1.2x
P/S Ratio-1.4x
P/E RatioIs EKSO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EKSO income statement (TTM) | |
|---|---|
| Revenue | US$18.28m |
| Cost of Revenue | US$9.20m |
| Gross Profit | US$9.08m |
| Other Expenses | US$24.28m |
| Earnings | -US$15.20m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.85 |
| Gross Margin | 49.67% |
| Net Profit Margin | -83.14% |
| Debt/Equity Ratio | 48.2% |
How did EKSO perform over the long term?
See historical performance and comparison